Combination antiperspirant and antimicrobial composition
View Patent ↗New medicaments and compositions having an antiperspirant agent and an antimicrobial agent, and methods based thereof, for control, prevention, amelioration, or treatment of perspiration and topical microbial contamination or infection of skin of the hands, feet, groin, face and other areas of the body, along with reduction or control of symptoms and side effects of such perspiration and microbial contamination or infection, are disclosed. Such medicaments and compositions can be used for various cosmetic, medicinal or pharmaceutical purposes, including control of microbial growth on gloved hands, control of microbial contamination of hands, control of chronic irritation or infection of hands, feet, groin, head, or other areas of skin associated with athletic participation, control of facial acne or other similar conditions, as a cosmetic foundation, or for control of foot odor or excessive foot perspiration.
1. Cosmetic and medicinal compositions adapted for applying an acne-inhibiting agent to the face comprising in a cosmetic foundations;
an antiperspirant agent and an antimicrobial agent,
wherein said antimicrobial agent is present at a concentration of from greater than zero to approximately 0.2%, and
wherein said antimicrobial agent is selected from the group consisting of alkydimethylbenzalkonium chloride, benzalkonium chloride, benzethonium chloride, benzyl alcohol, butylparaben, chlorhexidine, chlorobutanol, chloroxylenol, chloflucarban, cloquinol, cocamidopropyl PG-dimonium chloride phosphate, ethyl alcohol, farnesol, fluorosalan, hexachlorophene, hexylresorcinol, imidurea, iodine complex, isopropyl alcohol, mercufenol chloride, methylbenzethonium chloride, methylparaben, metronidazole, nonylphenoxypoly (ethyleneoxy) ethanoliodine, octoxy glycerine, phenol, poloxamer-iodine complex, polyhexamethylene buguanide (PHMB), propylparaben, providone iondine, quaternary ammonium compounds (QACs), secondary amyltricresols, sodium benzoate, sodium oxychlorosene, tribromsalan, triclocarban, triclosan, undecoylium chloride iodine complex, usnic acid and zinc phenosulfonate.
2. The compositions of claim 1 wherein said antiperspirant agent is selected from the group consisting of aluminum chlorohydrate, ‘activated’ aluminum chlorohydrate (AACH), aluminum chlorohydrate glycine complex, aluminum dichlorohydrate, aluminum sesquichlorohydrate, aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, aluminum zirconium trichlorohydrex glycine complex, aluminum zirconium tetrachlorohydrex glycine complex, aluminum zirconium pentachlorohydrex glycine complex, aluminum zirconium octachlorohydrex glycine complex, sodium aluminum chlorhydroxy lactate, aluminum zirconium tetrachlorohydrate, aluminum chlorohydrex PG complex, aluminum dichlorohydrex PG complex, aluminum sesquichlorohydrex PG complex, aluminum chlorohydrex PEG complex, aluminum dichlorohydrex PEG complex, aluminum sesquichlorohydrex PEG complex, ‘activated’ aluminum zirconium tetrachlorohydrex gly (AZAG), aluminum glycinate, zinc chlorohydrate, aluminum chloride, and aluminum sulfate.
3. The compositions of claim 1 further comprising an antiviral agent.
4. The compositions of claim 3 wherein said antiviral agent is selected from the group consisting of Nonoxydil-9, acyclovir, idoxuridine, and trifluridine.
5. The compositions of claim 1 further comprising a moisture sealant.
6. The compositions of claim 5 wherein said moisture sealant is selected from the group consisting of glycerine, glycocer, glycosphingolipid, mineral oil, petrolatum, polyethylene glycol and propylene glycol.
7. The compositions of claim 1 further comprising an anti-inflammatory agent.
8. The compositions of claim 7 wherein said anti-inflammatory agent is selected from the group consisting of alclometasone dipropionate, amcinonide, betamethasone valerate, betamethasone dipropionate, clobetasone propionate, desonide, desoximetasone, diflorasone diacetate, fluocinolone acetonide, fluocinonide, flurandrenolide, fluticasone propionate, halcinonide, hydrocortisone, mometasone furoate, and triamcincolone acetonide.
9. The compositions of claim 1 wherein at least one agent is encapsulated in a time-release vehicle.
10. The compositions of claim 1 , wherein said compositions are applied prior to application of make-up.
11. Topical cosmetic and medicinal compositions adapted for applying an acne-inhibiting agent to the face comprising:
an antiperspirant agent and an antimicrobial agent,
wherein said antimicrobial agent is present at a concentration of from greater than zero to approximately 0.2%, and
wherein said antimicrobial agent is selected from the group consisting of alkydimethylbenzalkonium chloride, benzalkonium chloride, benzethonium chloride, benzyl alcohol, butylparaben, chlorhexidine, chlorobutanol, chloroxylenol, chloflucarban, cloquinol, cocamidopropyl PG-dimonium chloride phosphate, ethyl alcohol, farnesol, fluorosalan, hexachlorophene, hexylresorcinol, imidurea, iodine complex, isopropyl alcohol, mercufenol chloride, methylbenzethonium chloride, methylparaben, metronidazole, nonylphenoxypoly (ethyleneoxy) ethanoliodine, octoxy glycerine, phenol, poloxamer-iodine complex, polyhexamethylene buguanide (PHMB), propylparaben, providone iondine, quaternary ammonium compounds (QACs), secondary amyltricresols, sodium benzoate, sodium oxychlorosene, tribromsalan, triclocarban, triclosan, undecoylium chloride iodine complex, usnic acid and zinc phenosulfonate.
12. The cosmetic and medicinal compositions of claim 11 further comprising an antiviral agent.
13. The cosmetic and medicinal compositions of claim 11 further comprising an additional agent selected from the group consisting of a bacteriocidal agent and a bacteriostatic agent.
14. The cosmetic and medicinal compositions of claim 11 further comprising a moisture sealant.
15. The cosmetic and medicinal compositions of claim 11 further comprising an anti-inflammatory agent.
16. The cosmetic and medicinal compositions of claim 11 wherein said compositions are formulated in a delivery vehicle selected from the group consisting of liquids, semisolids, solids and aerosols.
17. The cosmetic and medicinal compositions of claim 16 wherein said delivery vehicle is selected from the group consisting of creams, gels, hydrogels, liquids, and liquid suspensions.
18. The cosmetic and medicinal compositions of claim 11 wherein at least one agent is encapsulated in a time-release vehicle.
19. The cosmetic and medicinal compositions of claim 11 , wherein said compositions are applied prior to application of make-up.
20. A pharmaceutical composition in a vehicle adapted suitable for topical administration to the face comprising:
an antiperspirant agent and an antimicrobial agent for treatment of acne,
wherein said antimicrobial agent is present at a concentration of from greater than zero to approximately 0.2%, and
wherein said antimicrobial agent is selected from the group consisting of alkydimethylbenzalkonium chloride, benzalkonium chloride, benzethonium chloride, benzyl alcohol, butylparaben, chlorhexidine, chlorobutanol, chloroxylenol, chloflucarban, cloquinol, cocamidopropyl PG-dimonium chloride phosphate, ethyl alcohol, farnesol, fluorosalan, hexachlorophene, hexylresorcinol, imidurea, iodine complex, isopropyl alcohol, mercufenol chloride, methylbenzethonium chloride, methylparaben, metronidazole, nonylphenoxypoly (ethyleneoxy) ethanoliodine, octoxy glycerine, phenol, poloxamer-iodine complex, polyhexamethylene buguanide (PHMB), propylparaben, providone iondine, quaternary ammonium compounds (OACs), secondary amyltricresols, sodium benzoate, sodium oxychlorosene, tribromsalan, triclocarban, triclosan, undecoylium chloride iodine complex, usnic acid and zinc phenosulfonate.
21. The pharmaceutical composition of claim 20 wherein said antiperspirant agent is selected from the group consisting of aluminum chlorohydrate, ‘activated’ aluminum chlorohydrate (AACH), aluminum chlorohydrate glycine complex, aluminum dichlorohydrate, aluminum sesquichlorohydrate, aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, aluminum zirconium trichlorohydrex glycine complex, aluminum zirconium tetrachlorohydrex glycine complex, aluminum zirconium pentachlorohydrex glycine complex, aluminum zirconium octachlorohydrex glycine complex, sodium aluminum chlorhydroxy lactate, aluminum zirconium tetrachlorohydrate, aluminum chlorohydrex PG complex, aluminum dichlorohydrex PG complex, aluminum sesquichlorohydrex PG complex, aluminum chlorohydrex PEG complex, aluminum dichlorohydrex PEG complex, aluminum sesquichlorohydrex PEG complex, ‘activated’ aluminum zirconium tetrachlorohydrex (AZAG), aluminum glycinate, zinc chlorohydrate, aluminum chloride, and aluminum sulfate.
22. The pharmaceutical composition of claim 20 further comprising an antiviral agent.
23. The pharmaceutical composition of claim 22 wherein said antiviral agent is selected from the group consisting of Nonoxydil-9, acyclovir, idoxuridine, and trifluridine.
24. The pharmaceutical composition of claim 20 further comprising an anti-inflammatory agent.
25. The pharmaceutical composition of claim 24 wherein said ant-inflammatory agent is selected from the group consisting of alclometasone dipropionate, amcinonide, betamethasone valerate, betamethasone dipropionate, clobetasone propionate, desonide, desoximetasone, diflorasone diacetate, fluocinolone acetonide, fluocinonide, flurandrenolide, fluticasone propionate, halcinonide, hydrocortisone, mometasone furoate, and triamcincolone acetonide.
26. A pharmaceutical composition for topical administration comprising in a cosmetic foundation:
an antiperspirant agent and an antimicrobial agent for controlling the growth of bacteria associated with acne,
wherein said antimicrobial agent is present at a concentration of from greater than zero to approximately 0.2% and
wherein said antimicrobial agent is selected from the group consisting of alkydimethylbenzalkonium chloride, benzalkonium chloride, benzethonium chloride, benzyl alcohol, butylparaben, chlorhexidine, chlorobutanol, chloroxylenol, chloflucarban, cloquinol, cocamidopropyl PG-dimonium chloride phosphate, ethyl alcohol, farnesol, fluorosalan, hexachlorophene, hexylresorcinol, imidurea, iodine complex, isopropyl alcohol, mercufenol chloride, methylbenzethonium chloride, methylparaben, metronidazole, nonylphenoxypoly (ethyleneoxy) ethanoliodine, octoxy glycerine, phenol, poloxamer-iodine complex, polyhexamethylene buguanide (PHMB), propylparaben, providone iondine, quaternary ammonium compounds (QACs), secondary amyltricresols, sodium benzoate, sodium oxychlorosene, tribromsalan, triclocarban, triclosan, undecoylium chloride iodine complex, usnic acid and zinc phenosulfonate.
27. A method of reducing acne, excess sebum production and irritation caused by undesirable proliferation of dermatophytes comprising:
applying a topical composition consisting of an antiperspirant agent and an antimicrobial agent to the skin of the face or body,
wherein said antimicrobial agent is selected from the group consisting of alkydimethylbenzalkonium chloride, benzalkonium chloride, benzethonium chloride, benzyl alcohol, butylparaben, chlorhexidine, chlorobutanol, chloroxylenol, chloflucarban, cloquinol, cocamidopropyl PG-dimonium chloride phosphate, ethyl alcohol, farnesol, fluorosalan, hexachlorophene, hexylresorcinol, imidurea, iodine complex, isopropyl alcohol, mercufenol chloride, methylbenzethonium chloride, methylparaben, metronidazole, nonylphenoxypoly (ethyleneoxy) ethanoliodine, octoxy glycerine, phenol, poloxamer-iodine complex, polyhexamethylene buguanide (PHMB), propylparaben, providone iondine, quaternary ammonium compounds (QACs), secondary amyltricresols, sodium benzoate, sodium oxychlorosene, tribromsalan, triclocarban, triclosan, undecoylium chloride iodine complex, usnic acid and zinc phenosulfonate.